Filing Details
- Accession Number:
- 0001104659-22-067099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-01 16:01:27
- Reporting Period:
- 2022-05-27
- Accepted Time:
- 2022-06-01 16:01:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1829635 | Transcode Therapeutics Inc. | RNAZ | Pharmaceutical Preparations (2834) | 811065054 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1854161 | Michael Robert Dudley | C/O Transcode Therapeutics, Inc. 6 Liberty Square, #2382 Boston MA 02109 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-27 | 28,000 | $1.84 | 871,114 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-05-31 | 2,000 | $1.87 | 873,114 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |